ATE339222T1 - Verfahren zur herstellung eines human- papillomavirus-vakzins mit disassemblierten und reassemblierten virus-aehnlichen partikeln - Google Patents

Verfahren zur herstellung eines human- papillomavirus-vakzins mit disassemblierten und reassemblierten virus-aehnlichen partikeln

Info

Publication number
ATE339222T1
ATE339222T1 AT00918248T AT00918248T ATE339222T1 AT E339222 T1 ATE339222 T1 AT E339222T1 AT 00918248 T AT00918248 T AT 00918248T AT 00918248 T AT00918248 T AT 00918248T AT E339222 T1 ATE339222 T1 AT E339222T1
Authority
AT
Austria
Prior art keywords
disassembled
particles
producing
human papillomavirus
papillomavirus vaccine
Prior art date
Application number
AT00918248T
Other languages
English (en)
Inventor
David B Volkin
Henryk Mach
Li Shi
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26824774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE339222(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE339222T1 publication Critical patent/ATE339222T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00918248T 1999-03-26 2000-03-22 Verfahren zur herstellung eines human- papillomavirus-vakzins mit disassemblierten und reassemblierten virus-aehnlichen partikeln ATE339222T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12652899P 1999-03-26 1999-03-26
US09/524,624 US6245568B1 (en) 1999-03-26 2000-03-13 Human papilloma virus vaccine with disassembled and reassembled virus-like particles

Publications (1)

Publication Number Publication Date
ATE339222T1 true ATE339222T1 (de) 2006-10-15

Family

ID=26824774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918248T ATE339222T1 (de) 1999-03-26 2000-03-22 Verfahren zur herstellung eines human- papillomavirus-vakzins mit disassemblierten und reassemblierten virus-aehnlichen partikeln

Country Status (19)

Country Link
US (2) US6245568B1 (de)
EP (1) EP1165126B1 (de)
JP (1) JP4594534B2 (de)
KR (1) KR20020013516A (de)
AR (1) AR023166A1 (de)
AT (1) ATE339222T1 (de)
AU (1) AU778937B2 (de)
CA (1) CA2368391C (de)
CY (4) CY1105779T1 (de)
DE (4) DE122007000034I1 (de)
DK (1) DK1165126T3 (de)
ES (1) ES2270822T3 (de)
FR (1) FR07C0026I2 (de)
LT (1) LTC1165126I2 (de)
LU (3) LU91326I2 (de)
NL (3) NL300268I1 (de)
PT (1) PT1165126E (de)
SI (1) SI1165126T1 (de)
WO (1) WO2000057906A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351533B2 (en) 1997-09-05 2008-04-01 Medimmune, Inc. In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
US6962777B1 (en) * 1997-09-05 2005-11-08 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
ATE426803T1 (de) * 1999-12-09 2009-04-15 Medimmune Inc In-vitro-methode zur zerlegung und zum wiederzusammenfugen von papillomavirusartigen partikeln
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
EP1409013B1 (de) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Aluminiumadjuvans und histidin enthaltende impstoffe
DE10137102A1 (de) * 2001-07-30 2003-02-27 Deutsches Krebsforsch Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
AU2003217413A1 (en) * 2002-02-14 2003-09-04 Novavax, Inc. Method for isolation and purification of expressed gene products in vitro
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
DE10237639A1 (de) * 2002-08-13 2004-02-26 Martin-Luther-Universität Halle-Wittenberg Verfahren zur Herstellung von virusanalogen Partikeln durch in vitro-Assemblierung von Kapsomeren oder von Kapsomeren, an die biologisch aktive Makromoleküle gebunden sind, bei gleichzeitiger Verpackung der Makromoleküle
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
US8409587B2 (en) 2002-11-01 2013-04-02 Glaxosmithkline Biologicals S.A. Immunogenic composition
US7858098B2 (en) * 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
WO2004056389A1 (en) 2002-12-20 2004-07-08 Glaxosmithkline Biologicals Sa Hpv-16 and -18 l1 vlp vaccine
CA2572129A1 (en) * 2004-07-01 2006-01-12 The Circle For The Promotion Of Science And Engineering Viral particle-like construct and method of forming the same under physiological conditions
JP5312799B2 (ja) * 2005-01-25 2013-10-09 ファイザー アイルランド ファーマシューティカルズ 収集精密ろ過における剪断保護剤
AU2006270225A1 (en) * 2005-07-14 2007-01-25 Mayo Foundation For Medical Education And Research Paramyxoviridae virus preparations
EP1920779A4 (de) * 2005-08-12 2010-03-10 Astellas Pharma Inc Technik zur stabilisierung der yw753-reparatur
BRPI0520505B1 (pt) * 2005-09-01 2015-03-31 José Luis Nuño Ayalá Fórmula estabilizadora de vacinas com antígenos vivos para uso em sistemas de vacinação em massa
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
EP2024520B1 (de) * 2006-05-11 2014-03-05 Becton, Dickinson and Company Verfahren zur proteinextraktion aus zellen
US9207240B2 (en) * 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
EP2258380B1 (de) * 2008-03-31 2013-03-13 Morinaga Milk Industry Co., Ltd. Nukleinsäure zur erhöhung der wärmeresistenz von lactoferrin
BR112012004699B1 (pt) * 2009-09-03 2019-10-15 Becton, Dickinson And Company Métodos, composições e kits para lise química direta
PL3246044T5 (pl) 2010-08-23 2024-06-17 Wyeth Llc Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
PE20140173A1 (es) 2010-09-10 2014-02-20 Wyeth Llc Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis
EP4043029A1 (de) 2012-03-09 2022-08-17 Pfizer Inc. Neisseria meningitidis-zusammensetzungen und verfahren dafür
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
BR112014023092A8 (pt) 2012-03-18 2017-07-25 Glaxosmithkline Biologicals Sa Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
EP3041502A2 (de) 2013-09-08 2016-07-13 Pfizer Inc. Neisseria meningitidis-zusammensetzungen und verfahren dafür
US10888611B2 (en) 2015-02-19 2021-01-12 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
JP7010961B2 (ja) 2017-01-31 2022-02-10 ファイザー・インク 髄膜炎菌組成物およびその方法
US20200010850A1 (en) 2017-02-17 2020-01-09 The USA, as represeented by the Secretary, Dept. of Health and Human Services Efficient cell free production of papillomavirus gene transfer vectors
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
KR102871663B1 (ko) 2019-09-27 2025-10-16 화이자 인코포레이티드 네이세리아 메닌기티디스 조성물 및 그의 방법
CN110987571A (zh) * 2019-12-31 2020-04-10 广州金域医学检验中心有限公司 一种单克隆多聚体m蛋白解聚方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2278684C (en) * 1997-02-06 2007-04-10 Merck & Co., Inc. Thimerosal-free preservatives for vaccines
DK0973546T3 (da) 1997-04-08 2004-06-28 Merck & Co Inc Stabiliserede formuleringer med human papillomavirus
EP1000157A1 (de) 1997-07-03 2000-05-17 University Technology Corporation Zusammensetzungen, die homogene kapsomere des menschlichen papillomavirus enthalten, verfahren zu ihrer herstellung und ihre verwendung in der diagnose, prophylaxe und therapie

Also Published As

Publication number Publication date
FR07C0026I1 (de) 2007-04-27
LTPA2007002I1 (lt) 2020-03-25
CA2368391C (en) 2011-06-07
DE60030698D1 (de) 2006-10-26
LU91326I2 (fr) 2007-05-14
CY2007010I2 (el) 2009-11-04
NL300270I1 (nl) 2007-05-01
JP4594534B2 (ja) 2010-12-08
CA2368391A1 (en) 2000-10-05
EP1165126B1 (de) 2006-09-13
EP1165126A1 (de) 2002-01-02
JP2002540167A (ja) 2002-11-26
DK1165126T3 (da) 2007-01-08
US6245568B1 (en) 2001-06-12
ES2270822T3 (es) 2007-04-16
CY2007009I1 (el) 2010-07-28
AU3909300A (en) 2000-10-16
NL300268I1 (nl) 2007-05-01
LU91327I2 (fr) 2007-05-14
DE122007000032I1 (de) 2007-08-09
SI1165126T1 (sl) 2006-12-31
LU91327I9 (de) 2019-03-01
CY2007010I1 (el) 2009-11-04
PT1165126E (pt) 2006-12-29
KR20020013516A (ko) 2002-02-20
AR023166A1 (es) 2002-09-04
CY2007009I2 (el) 2010-07-28
US20010021385A1 (en) 2001-09-13
AU778937B2 (en) 2004-12-23
LU91328I9 (de) 2019-03-01
WO2000057906A1 (en) 2000-10-05
NL300269I1 (nl) 2007-05-01
CY2007008I1 (el) 2009-11-04
DE60030698T2 (de) 2007-07-19
CY2007008I2 (el) 2009-11-04
LTC1165126I2 (lt) 2020-04-27
NL300269I2 (nl) 2008-07-01
DE122007000033I1 (de) 2007-08-09
LU91326I9 (de) 2018-12-31
DE122007000034I1 (de) 2007-08-09
CY1105779T1 (el) 2010-07-28
FR07C0026I2 (fr) 2012-08-03
LU91328I2 (fr) 2007-05-14

Similar Documents

Publication Publication Date Title
ATE339222T1 (de) Verfahren zur herstellung eines human- papillomavirus-vakzins mit disassemblierten und reassemblierten virus-aehnlichen partikeln
DE60028870D1 (de) Verfahren und Vorrichtung zur Herstellung eines zweiteiligen Kolbens
DE60218386D1 (de) Verfahren und System zur Erstellung eines dentalen Modells mittels Bildgebung
DE60204022D1 (de) Verfahren zur herstellung eines poly(arylenether)s und danach hergestellter poly(arylenether)
DE60005793D1 (de) Verfahren zur herstellung eines schleifgegenstandes und damit hergestellte schleifgegenstände
DE50010576D1 (de) Verfahren zur herstellung eines knochenimplantats
DE60136853D1 (de) Verfahren zur herstellung eines fullerenderivats
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
DE50207943D1 (de) Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE50110765D1 (de) Verfahren und vorrichtung zur herstellung eines bandförmigen gegenstandes
DE60141806D1 (de) Silikongummi in form eines feinverteilten puders sowie verfahren zur herstellung und verwendung desselben
DE60119307D1 (de) Verfahren zur herstellung eines fluorionomers, verfahren zur reinigung und konzentrierung von ionomeren und verfahren zur filmbildung
DE69912998D1 (de) Herzklappe und verfahren zu herstellung eines biologischen gewebes
DE60326329D1 (de) Verfahren zur herstellung eines keramikwabenstrukturkörpers und keramikwabenstrukturkörper
DE60102862T2 (de) Verfahren zur herstellung eines feuerdetektors und feuerdetektor
AU2003271021A1 (en) Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
DE60017710D1 (de) Verfahren zur herstellung eines nickelpulvers
DE60139452D1 (de) Verfahren zur Herstellung eines Blutsammelbehälters und eines Zusatzes
DE50208869D1 (de) Verfahren und vorrichtung zur herstellung eines zylinderförmigen glaskörpers
DE50113842D1 (de) Computertomographie-Verfahren zur Erzeugung eines Scannogramms
DE60000465D1 (de) Verfahren und Vorrichtung zur Herstellung eines Verbundmaterials
DE50115727D1 (de) Piezoaktor und verfahren zur herstellung eines piezoaktors
DE60116275D1 (de) Verfahren zur herstellung eines titansilicalitformkörpers
DE50001906D1 (de) Verfahren zur herstellung eines gesinterten wabenkörpers
AU6964001A (en) Vaccine against the influenza virus and method for producing said virus vaccine